Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
1.
Blood Cells Mol Dis ; 46(1): 75-84, 2011 Jan 15.
Article in English | MEDLINE | ID: mdl-20880730

ABSTRACT

Gaucher disease (GD), the most common lysosomal storage disease, results from a deficiency of the lysosomal enzyme glucocerebrosidase. GD has been classified into 3 types, of which type 2 (the acute neuronopathic form) is the most severe, presenting pre- or perinatally, or in the first few months of life. Traditionally, type 2 GD was considered to have the most uniform clinical phenotype when compared to other GD subtypes. However, case studies over time have demonstrated that type 2 GD, like types 1 and 3, manifests with a spectrum of phenotypes. This review includes case reports that illustrate the broad range of clinical presentations encountered in type 2 GD, as well as a discussion of associated manifestations, pathological findings, diagnostic techniques, and a review of current therapies. While type 2 GD is generally associated with severe mutations in the glucocerebrosidase gene, there is also significant genotypic heterogeneity.


Subject(s)
Gaucher Disease/genetics , Gaucher Disease/pathology , Genetic Variation , Glucosylceramidase/genetics , Phenotype , Female , Gaucher Disease/physiopathology , Gaucher Disease/therapy , Genotype , Humans , Infant , Infant, Newborn , Male
2.
Blood Cells Mol Dis ; 46(1): 39-41, 2011 Jan 15.
Article in English | MEDLINE | ID: mdl-21056933

ABSTRACT

We describe monozygotic twin sisters, born to consanguineous Moroccan parents, who are highly discordant for the manifestations of Gaucher disease. Both carry Gaucher genotype N188S/N188S. One has severe visceral involvement, epilepsy, and a cerebellar syndrome. Her twin does not manifest any symptoms or signs of Gaucher disease but suffers from type 1 diabetes mellitus. The concurrence of a mild Gaucher mutation with a severe phenotype, as well as the occurrence of highly discordant phenotypes in a pair of monozygotic twins, is discussed.


Subject(s)
Cerebellar Diseases/etiology , Diabetes Mellitus, Type 1/complications , Diseases in Twins , Gaucher Disease , Phenotype , Twins, Monozygotic , Adolescent , Adult , Female , Gaucher Disease/complications , Gaucher Disease/diagnosis , Gaucher Disease/genetics , Gaucher Disease/pathology , Genotype , Glucosylceramidase/blood , Humans , Morocco , Mutation , Twins, Monozygotic/genetics , Young Adult
4.
Mol Genet Metab ; 79(2): 104-9, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12809640

ABSTRACT

Among the phenotypes associated with Gaucher disease, the deficiency of glucocerebrosidase, are rare patients with early onset, treatment-refractory parkinsonism. Sequencing of glucocerebrosidase in 17 such patients revealed 12 different genotypes. Fourteen patients had the common "non-neuronopathic" N370S mutation, including five N370S homozygotes. While brain glucosylsphingosine levels were not elevated, Lewy bodies were seen in the four brains available for study. The shared clinical and neuropathologic findings in this subgroup suggest that the deficiency in glucocerebrosidase may contribute to a vulnerability to parkinsonism.


Subject(s)
Gaucher Disease/genetics , Genetic Predisposition to Disease , Glucosylceramidase/deficiency , Glucosylceramidase/genetics , Parkinson Disease/etiology , Sphingosine/analogs & derivatives , Adult , Blotting, Southern , Brain/metabolism , Brain/pathology , Deoxyribonucleases, Type II Site-Specific/genetics , Female , Gaucher Disease/complications , Gaucher Disease/metabolism , Gaucher Disease/pathology , Homozygote , Humans , Levodopa/therapeutic use , Male , Middle Aged , Mutation , Parkinson Disease/drug therapy , Parkinson Disease/metabolism , Parkinson Disease/pathology , Psychosine/analogs & derivatives , Sphingosine/metabolism
6.
Hum Mutat ; 19(4): 458-9, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11933202

ABSTRACT

Mutations in the gene encoding for the lysosomal enzyme glucocerebrosidase (GBA) result in Gaucher disease. In this study, seven novel missense mutations in the glucocerebrosidase gene (A136E, H162P, K198E, Y205C, F251L, Q350X and I402F) and a splice site mutation (IVS10+2T-->A) were identified by direct sequencing of three amplified segments of the glucocerebrosidase gene. Five of the novel mutations were found in patients with neuronopathic forms of Gaucher disease, two of which, K198E and F251L, appear to be associated with type 2 Gaucher disease.


Subject(s)
Gaucher Disease/genetics , Glucosylceramidase/genetics , Mutation, Missense/genetics , RNA Splice Sites/genetics , Alleles , Consanguinity , DNA Mutational Analysis , Ethnicity/genetics , Exons/genetics , Gaucher Disease/classification , Humans , Racial Groups/genetics
7.
Clin Genet ; 61(1): 32-4, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11903352

ABSTRACT

Gaucher disease is caused by mutations in the gene for human glucocerebrosidase, a lysosomal enzyme involved in the intracellular hydrolysis of glucosylceramide. While over 150 different glucocerebrosidase mutations have been identified in patients with Gaucher disease, not all reported mutations have been fully characterized as being causative. One such mutation is the E326K mutation, which results from a G to A nucleotide substitution at genomic position 6195 and has been identified in patients with type 1, type 2 and type 3 Gaucher disease. However, in each instance, the E326K mutation was found on the same allele with another glucocerebrosidase mutation. Utilizing polymerase chain reaction (PCR) screening and restriction digestions of both patients with Gaucher disease and normal controls, we identified the E326K allele in both groups. Of the 310 alleles screened from patients with Gaucher disease, the E326K mutation was detected in four alleles (1.3%). In addition, screening for the E326K mutation among normal controls from a random population revealed that three alleles among 316 screened (0.9%) also carried the E326K mutation. In the normal controls with the E326K allele, the glucocerebrosidase gene was completely sequenced, but no additional mutations were found. Because the E326K mutation may be a polymorphism, we caution that a careful examination of any allele with this mutation should be performed to check for the presence of other glucocerebrosidase mutations.


Subject(s)
Gaucher Disease/genetics , Glucosylceramidase/genetics , Mutation, Missense/genetics , Polymorphism, Genetic/genetics , Alleles , Case-Control Studies , Cells, Cultured , DNA Mutational Analysis , Female , Gaucher Disease/enzymology , Glucosylceramidase/chemistry , Humans , Male
8.
Mol Genet Metab ; 73(4): 313-21, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11509013

ABSTRACT

Among the many phenotypes associated with Gaucher disease, the inherited deficiency of glucocerebrosidase, are reports of patients with parkinsonian symptoms. The basis for this association is unknown, but could be due to alterations in the gene or gene region. The human glucocerebrosidase gene, located on chromosome 1q21, has a nearby pseudogene that shares 96% identity. Immediately adjacent to the glucocerebrosidase pseudogene is a convergently transcribed gene, metaxin, which has a pseudogene that is located just downstream to the glucocerebrosidase gene. We describe a patient with mild Gaucher disease but impaired horizontal saccadic eye movements who developed a tremor at age 42, followed by rapid deterioration of her gait. A pallidotomy at age 47 was unsuccessful. Her motor and cognitive deterioration progressed despite enzyme replacement therapy. Sequencing of the glucocerebrosidase gene identified mutations L444P and D409H. Southern blot analysis using the enzyme SspI showed that the maternal allele had an additional 17-kb band. PCR amplifications and sequencing of this fragment demonstrated a duplication which included the glucocerebrosidase pseudogene, metaxin gene, and a pseudometaxin/metaxin fusion. Gene alterations associated with this novel rearrangement, resulting from a crossover between the gene for metaxin and its pseudogene, could contribute to the atypical phenotype encountered in this patient.


Subject(s)
Gaucher Disease/genetics , Gaucher Disease/physiopathology , Glucosylceramidase/genetics , Parkinson Disease, Secondary/complications , Parkinson Disease, Secondary/genetics , Ubiquitin-Protein Ligases , Alleles , Blotting, Southern , Chromosomes, Human, Pair 1/genetics , Crossing Over, Genetic/genetics , DNA Mutational Analysis , Female , Gaucher Disease/enzymology , Gaucher Disease/therapy , Genotype , Glucosylceramidase/deficiency , Glucosylceramidase/metabolism , Glucosylceramidase/therapeutic use , Humans , In Situ Hybridization, Fluorescence , Ligases/genetics , Male , Middle Aged , Mitochondrial Membrane Transport Proteins , Nerve Tissue Proteins/genetics , Parkinson Disease, Secondary/enzymology , Parkinson Disease, Secondary/physiopathology , Phenotype , Physical Chromosome Mapping , Polymorphism, Genetic/genetics , Proteins/genetics , Pseudogenes/genetics , RNA, Messenger/analysis , RNA, Messenger/genetics , Synucleins
9.
Am J Med Genet ; 99(2): 147-51, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11241475

ABSTRACT

While the inherited deficiency of the enzyme glucocerebrosidase (Gaucher disease) is panethnic in its distribution, there have not been studies of the mutations encountered in specific ethnic groups in the United States, other than those on Ashkenazi Jews. We present the clinical descriptions and genotypes of seven patients of African-American ancestry with type 1 Gaucher disease, and summarize the published literature regarding the genotypes encountered in this population. All seven of the patients had moderate-to-severe manifestations of the disease, and all developed symptoms by adolescence. Genotypic analyses revealed that no two probands shared the same genotype. The common mutations N370S, c.84-85insG, IVS2+1 G-->A, and R463C were not seen. Mutation L444P was present on one allele in each of the patients; but the same mutation was encountered as a single point mutation in three of the patients, and as part of a recombinant allele in four of the patients. Southern blot analyses revealed a glucocerebrosidase fusion allele in one patient, and a duplication resulting from recombination in the region downstream from the glucocerebrosidase gene in three of the patients. Five different point mutations (A90T, R48W, N117D, R170C, and V352L), one deletion mutation (c.222-224 delTAC), and one insertion mutation (c.153-154 insTACAGC) were encountered. Our results demonstrate that there is significant genotypic heterogeneity among African-American patients with type 1 Gaucher disease, and that recombinations in the glucocerebrosidase gene locus are particularly common in this patient group. Published 2001 Wiley-Liss, Inc.


Subject(s)
Gaucher Disease/enzymology , Glucosylceramidase/genetics , Mutation , Adolescent , Adult , Black or African American , Black People/genetics , DNA Mutational Analysis , Female , Gaucher Disease/genetics , Genetic Heterogeneity , Genotype , Humans , Infant , Male , Molecular Sequence Data
10.
Hum Genet ; 107(4): 400-3, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11129343

ABSTRACT

The genes for glucocerebrosidase and metaxin, both located on chromosome 1q21, each have a highly homologous pseudogene sequence nearby. We describe a novel recombinant allele consisting of a duplication of the glucocerebrosidase pseudogene and a fusion between the metaxin gene and its pseudogene, resulting from a crossover between metaxin and pseudometaxin in the region downstream of the glucocerebrosidase gene. We also show that certain individuals have a metaxin-pseudometaxin fusion gene without a duplication, resulting from the same crossover. DNA from patients with Gaucher disease and normal controls were screened for recombinant alleles by Southern blot analyses prepared with the restriction enzymes SspI and HincII and by direct sequencing. Downstream alterations were identified in eight of the 398 patient alleles studied and in seven of the 200 normal control alleles examined, and were encountered more frequently among patients and controls of African-American ancestry. This is the first recognition of a duplicated allele in the glucocerebrosidase gene region, and its presence may contribute to genotype-phenotype studies in Gaucher disease.


Subject(s)
Chromosomes, Human, Pair 1/genetics , Glucosylceramidase/genetics , Proteins/genetics , Pseudogenes , Alleles , Artificial Gene Fusion , Black People/genetics , Case-Control Studies , Crossing Over, Genetic , Gaucher Disease/enzymology , Gaucher Disease/genetics , Gene Duplication , Gene Rearrangement , Genotype , Humans , Mitochondrial Membrane Transport Proteins , Phenotype
12.
Am J Hum Genet ; 66(6): 1777-86, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10796875

ABSTRACT

Gaucher disease results from the inherited deficiency of the enzyme glucocerebrosidase (EC 3.2.1.45). Although >100 mutations in the gene for human glucocerebrosidase have been described, most genotype-phenotype studies have focused upon screening for a few common mutations. In this study, we used several approaches-including direct sequencing, Southern blotting, long-template PCR, restriction digestions, and the amplification refraction mutation system (ARMS)-to genotype 128 patients with type 1 Gaucher disease (64 of Ashkenazi Jewish ancestry and 64 of non-Jewish extraction) and 24 patients with type 3 Gaucher disease. More than 97% of the mutant alleles were identified. Fourteen novel mutations (A90T, N117D, T134I, Y135X, R170C, W184R, A190T, Y304X, A341T, D399Y, c.153-154insTACAGC, c.203-204insC, c.222-224delTAC, and c.1122-1123insTG) and many rare mutations were detected. Recombinant alleles were found in 19% of the patients. Although 93% of the mutant alleles in our Ashkenazi Jewish type 1 patients were N370S, c.84-85insG, IVS2+1G-->A or L444P, these four mutations accounted for only 49% of mutant alleles in the non-Jewish type 1 patients. Genotype-phenotype correlations were attempted. Homozygosity or heterozygosity for N370S resulted in type 1 Gaucher disease, whereas homozygosity for L444P was associated with type 3. Genotype L444P/recombinant allele resulted in type 2 Gaucher disease, and homozygosity for a recombinant allele was associated with perinatal lethal disease. The phenotypic consequences of other mutations, particularly R463C, were more inconsistent. Our results demonstrate a high rate of mutation detection, a large number of novel and rare mutations, and an accurate assessment of the prevalence of recombinant alleles. Although some genotype-phenotype correlations do exist, other genetic and environmental factors must also contribute to the phenotypes encountered, and we caution against relying solely upon genotype for prognostic or therapeutic judgements.


Subject(s)
Gaucher Disease/classification , Gaucher Disease/genetics , Mutation/genetics , Alleles , Crossing Over, Genetic/genetics , DNA Mutational Analysis , Environment , Gaucher Disease/enzymology , Gaucher Disease/physiopathology , Gene Frequency/genetics , Genes, Lethal/genetics , Genotype , Glucosylceramidase/genetics , Humans , Jews/genetics , Models, Genetic , Mutation, Missense/genetics , Phenotype , Polymerase Chain Reaction , Pseudogenes/genetics
13.
Arch Dis Child Fetal Neonatal Ed ; 82(2): F163-6, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10685993

ABSTRACT

The association of Gaucher disease, the inherited deficiency of lysosomal glucocerebrosidase (EC 3.2.1.45), and congenital ichthyosis was first noted a decade ago. Subsequently, a null allele type 2 Gaucher mouse was generated that also exhibited ichthyotic skin, confirming that the skin disorder and enzyme deficiency were directly related. This paper details the clinical and molecular characterisation of 6 cases of type 2 Gaucher disease presenting with the collodion baby phenotype. The identified mutant glucocerebrosidase alleles include two novel mutations (S196P and R131L) and two rare point mutations (R120W and R257Q), as well as alleles resulting from recombination with the nearby glucocerebrosidase pseudogene. There is significant genotypic heterogeneity in this rare subset of patients with type 2 Gaucher disease. Gaucher disease should be considered in the differential diagnosis of congenital ichthyosis in the newborn period.


Subject(s)
Gaucher Disease/genetics , Ichthyosis/genetics , Mutation/genetics , Blotting, Southern/methods , DNA Mutational Analysis , Fatal Outcome , Female , Gaucher Disease/complications , Humans , Ichthyosis/complications , Infant, Newborn , Male , Phenotype
14.
Hum Mutat ; 15(2): 181-8, 2000.
Article in English | MEDLINE | ID: mdl-10649495

ABSTRACT

Gaucher disease, the most common lysosomal storage disorder, results from the inherited deficiency of the enzyme glucocerebrosidase. Three clinical types are recognized: type 1, non-neuronopathic; type 2, acute neuronopathic; and type 3, subacute neuronopathic. Type 2 Gaucher disease, the rarest type, is progressive and fatal. We have performed molecular analyses of a cohort of 31 patients with type 2 Gaucher disease. The cases studied included fetuses presenting prenatally with hydrops fetalis, infants with the collodion baby phenotype, and infants diagnosed after several months of life. All 62 mutant glucocerebrosidase (GBA) alleles were identified. Thirty-three different mutant alleles were found, including point mutations, splice junction mutations, deletions, fusion alleles and recombinant alleles. Eleven novel mutations were identified in these patients: R131L, H255Q, R285H, S196P, H311R, c.330delA, V398F, F259L, c.533delC, Y304C and A190E. Mutation L444P was found on 25 patient alleles. Southern blots and direct sequencing demonstrated that mutation L444P occurred alone on 9 alleles, with E326K on one allele and as part of a recombinant allele on 15 alleles. There were no homozygotes for point mutation L444P. The recombinant alleles that included L444P resulted from either reciprocal recombination or gene conversion with the nearby glucocerebrosidase pseudogene, and seven different sites of recombination were identified. Homozygosity for a recombinant allele was associated with early lethality. We have also summarized the literature describing mutations associated with type 2 disease, and list 50 different mutations. This report constitutes the most comprehensive molecular study to date of type 2 Gaucher disease, and it demonstrates that there is significant phenotypic and genotypic heterogeneity among patients with type 2 Gaucher disease. Hum Mutat 15:181-188, 2000. Published 2000 Wiley-Liss, Inc.


Subject(s)
Gaucher Disease/enzymology , Gaucher Disease/genetics , Glucosylceramidase/genetics , Mutation/genetics , Alleles , Ethnicity/genetics , Exons/genetics , Gaucher Disease/classification , Gaucher Disease/embryology , Genes, Lethal/genetics , Genetic Heterogeneity , Humans , Infant , Pseudogenes/genetics , Recombinant Fusion Proteins/genetics
16.
Mol Psychiatry ; 4(5): 414, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10523812
17.
Eur J Hum Genet ; 7(4): 505-9, 1999.
Article in English | MEDLINE | ID: mdl-10352942

ABSTRACT

In recent years there has been increased recognition of a severe perinatal lethal form of Gaucher disease, the inherited deficiency of lysosomal glucocerebrosidase. We previously reported a case of severe type 2 Gaucher disease which was seen in a medical center in Rotterdam and now present three new cases from two other families seen at the same center. Mutational analyses of these cases revealed two novel mutations, H311R and V398F, located in exons 8 and 9, respectively. The identification of four cases of lethal type 2 Gaucher disease in a single center seems to be a function of increased awareness of this phenotype, rather than of geographic clustering. The actual incidence of lethal type 2 Gaucher disease may be underestimated, as many cases may have been misclassified as collodion babies or hydrops of unknown cause.


Subject(s)
Gaucher Disease/epidemiology , Gaucher Disease/genetics , Glucosylceramidase/genetics , DNA Mutational Analysis , Exons/genetics , Fatal Outcome , Female , Fibroblasts/pathology , Gaucher Disease/pathology , Humans , Infant, Newborn , Male , Pregnancy , Skin/pathology
18.
Hum Genet ; 104(4): 293-300, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10369158

ABSTRACT

Gaucher disease, an inherited glycolipid storage disorder, is caused by a deficiency of the catabolic enzyme glucocerebrosidase (EC 3.2.1.45). The gene for human glucocerebrosidase is located on chromosome 1q21 and has a highly homologous pseudogene situated 16 kb downstream. We report two novel polymorphic sequences in the glucocerebrosidase gene region: the first consists of a variable number of dinucleotide (CT) repeats located 3.2 kb upstream from the glucocerebrosidase gene, and the second is a tetranucleotide (AAAT) repeat found between the glucocerebrosidase gene and its pseudogene, 9.8 kb downstream from the functional gene. These polymorphic sequences, along with a previously reported PvuII polymorphism in intron 6 of the glucocerebrosidase gene, were analyzed in patients with Gaucher disease (n=106) and in two normal control populations, one of Ashkenazi Jewish ancestry (n=72) and the second comprising non-Jewish individuals (n=46). In these samples, strong linkage disequilibrium was found between mutations N370S, c.84-85insG, and R463C and specific haplotypes; no significant linkage disequilibrium was found when examining haplotypes of patients with the L444P mutation. Studies of these polymorphic sites in several instances also led to the recognition of genotyping errors and the identification of unusual recombinant alleles. These new polymorphic sites provide additional tools for mutational screening and founder effect studies of Gaucher disease.


Subject(s)
Founder Effect , Gaucher Disease/genetics , Glucosylceramidase/genetics , Polymorphism, Restriction Fragment Length , Amino Acid Substitution , Cell Line , Chromosome Mapping , Chromosomes, Human, Pair 1 , DNA/blood , DNA/genetics , DNA Mutational Analysis , Deoxyribonucleases, Type II Site-Specific , Dinucleotide Repeats , Gaucher Disease/enzymology , Humans , Jews/genetics , Linkage Disequilibrium , Point Mutation , Pseudogenes
19.
Mol Psychiatry ; 3(5): 431-4, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9774777

ABSTRACT

Although the etiology of attention-deficit/hyperactivity disorder (ADHD) is likely multifactorial, family, adoption, and twin studies suggest that genetic factors contribute significantly. Polymorphisms of the dopamine 4 receptor (DRD4) affect receptor binding, and one allele with seven tandem repeats in exon 3 (DRD4*7R) has been associated with ADHD. We examined this putative association in 41 children with severe ADHD and 56 healthy controls who were group matched for ethnicity and sex. The frequency of the DRD4*7R allele did not vary by diagnosis (0.220 vs 0.205 in patients and controls, respectively). Behavioral and brain anatomic MRI measures, previously found to discriminate patients from controls, did not differ significantly between subjects having and those lacking a DRD4*7R allele. These data do not support the reported association between DRD4*7R and the behavioral or brain morphometric phenotype associated with ADHD.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Attention Deficit Disorder with Hyperactivity/pathology , Brain/anatomy & histology , Child Behavior , Polymorphism, Genetic , Receptors, Dopamine D2/genetics , Alleles , Attention Deficit Disorder with Hyperactivity/psychology , Child , Female , Humans , Magnetic Resonance Imaging , Male , Parents , Receptors, Dopamine D4 , Reference Values , Repetitive Sequences, Nucleic Acid , Schools
20.
Mol Genet Metab ; 63(4): 281-8, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9635296

ABSTRACT

Gaucher disease, the deficiency of the lysosomal enzyme glucocerebrosidase (EC 3.2.1.45), is frequently encountered in the Ashkenazi Jewish population. Carrier screening for Gaucher disease by enzyme analysis performed during a routine pregnancy indicated that both Ashkenazi parents were carriers. Screening for four common Gaucher mutations was subsequently performed on fetal and parental DNA. None of the common Ashkenazi mutations were identified. However, when exons 9-11 were amplified and digested with NciI to detect the L444P mutation, it appeared that the mother and the fetus had an unusual allele and that the expected paternal allele was not present. When the fetal amniocytes were found to have less than 2% of the normal glucocerebrosidase activity and a fetal sonogram revealed hydrops fetalis, the pregnancy was terminated. The diagnosis of severe type 2 Gaucher disease was confirmed at autopsy. Ultrastructural studies of epidermis from the fetus revealed the characteristic disruption of lamellar bilayers, diagnostic for type 2 Gaucher disease. In subsequent studies of the fetal DNA, long-template polymerase chain reaction amplification revealed one appropriately sized band (approximately 6.5 kb) and one smaller (approximately 5.2 kb) band. Sequencing of the approximately 5.2-kb fragment identified a novel fusion allele resulting from recombination between the glucocerebrosidase gene and its pseudogene beginning in intron 3. This fusion allele was inherited from the father. The result was confirmed by Southern blot analysis using the enzyme S8tII. Sequencing of the 6.5-kb fragment identified a previously described, although rare, T-to-G splice junction mutation in intron 10 of the maternal allele, which introduced an NciI site. The couple had a subsequent pregnancy which was also found to be affected. This case study identifies a novel recombinant allele and an unusual splice junction mutation, and demonstrates that even in the Ashkenazi population, screening for common mutations may not accurately identify the most severe forms of the disease.


Subject(s)
Alleles , Alternative Splicing/genetics , Gaucher Disease/genetics , Glucosylceramidase/genetics , Hydrops Fetalis/genetics , Point Mutation , Base Sequence , Female , Humans , Jews/genetics , Male , Molecular Sequence Data , Polymerase Chain Reaction , Pregnancy , Prenatal Diagnosis , Recombination, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...